Cue Biopharma, Inc. ( CUE) - Key Metrics
CUE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $0.20 | $0.01 | -$0.01 | -$0.01 |
| 2025Q3 | $0.02 | -$0.07 | -$0.09 | -$0.09 |
| 2025Q2 | $0.03 | -$0.09 | -$0.04 | -$0.04 |
| 2025Q1 | $0.01 | -$0.17 | -$0.11 | -$0.11 |
| 2024Q4 | $0.02 | -$0.13 | -$0.12 | -$0.12 |
CUE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | 5.20 |
| 2025Q3 | ? | -2.43 |
| 2025Q2 | ? | -1.92 |
| 2025Q1 | ? | -1.38 |
| 2024Q4 | ? | -2.13 |
CUE
Price: $28.46
52 week price:
Earnings Per Share: -8.40 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 255300
Market Capitalization: 67.5 million